Daniel Quesada retweeted
🌎 New #GlobalCardiacRehabAudit findings from Latin America & the Caribbean:
⚠️ Median coverage for incident #cardiac patients/country: 3%
💲 55% of patients pay out-of-pocket
❤️ Multidisciplinary staff of 5 delivered comprehensive care (9/10 components)
📖 bit.ly/3TnRiQM
@BrazJPhysTher
@ASSOBRAFIR
@SUC_cardiologia
@sccccardio
@GlobalHeartHub
@worldheartfed
@gabrielamghisi
@sherrylgrace
@ClaudiaAnchique
@drdquesada
@pame_seron
@AdawiTurk
@LilianMbau
@drMSupervia
Daniel Quesada retweeted
#ACC26 is coming — I need your input 👇 ahead of my session
If you could choose ONLY ONE drug to promote LV recovery in HFrEF… which would you prioritize?
🔄 RT so we can get more real-world 🌎 answers
44%ARNI
31%SGLT2i
7%MRA
18%BB
89 votes • Final results Daniel Quesada retweeted
Caffeine metabolism and why coffee hits people differently
1️⃣ Absorption Is Fast
Caffeine is absorbed in the stomach & small intestine, peaking in blood within 30–60 min.
💡 why that morning espresso kicks in quick.
2️⃣ The Liver Is the Gatekeeper
CYP1A2 enzyme (a liver detox enzyme) breaks caffeine down.
💡 Some people have a “fast” version, others a “slow” one.
3️⃣ Three Metabolites Dominate
Paraxanthine → boosts alertness, fat metabolism.
Theobromine → widens blood vessels (and is in chocolate).
Theophylline → relaxes airways (like old asthma drugs).
4️⃣ Genetics Decide Your Buzz
Fast metabolizers clear caffeine quickly (need more cups).
Slow metabolizers keep caffeine in their system for hours (jitters, insomnia).
5️⃣ Lifestyle Tweaks It
Smoking speeds caffeine breakdown.
Pregnancy & certain meds slow it.
💡 Same coffee, different effects.
6️⃣ Half-Life Matters
Caffeine’s half-life = ~5 hours, but in slow metabolizers it can stretch to 9+.
💡 That 3 p.m. latte may still be in your bloodstream at midnight.
7️⃣ Tolerance Builds
Regular caffeine users adapt at the receptor level, needing more to feel the same effect.
💡 Why quitting leads to headaches & fatigue.
Daniel Quesada retweeted
¡HOY!
@cifacah los invita hoy al webinar:
ESC 2025 Highlights en Falla Cardíaca por CIFACAH
Resultados y su impacto en la Práctica Clínica.
🗓️ Martes 23 de septiembre
🕕 18:00 horas 🇨🇴
🔗Inscripción sin costo: us02web.zoom.us/webinar/regi…
@SIAC_cardio @FallaCardiaca @sccccardio
Daniel Quesada retweeted
Desde el Congreso Europeo de Cardiología, en Madrid 🇪🇸
El presidente de nuestro Consejo @cifacah
Dr Walter Alarco 🇵🇪
@SIAC_cardio @sopecard1947 @rossel_victor @Bernilina @RiveraToquicaMD @EduardoPerna1
Daniel Quesada retweeted
Ahora en #ESCCongress
“State of the art lecture on treatment of HFpEF”
Dra @carolynlam
@htp_ic @SIAC_cardio @gonzaeperez @EduardoPerna1 @rossel_victor @RiveraToquicaMD @Walarco1 @MarcoMetra @Guilleresperon
Daniel Quesada retweeted
Hoy tuvimos nuestra Asamblea general
Gracias por liderarnos en el periodo 2023-2025 como Presidente al Dr @rossel_victor y Secretario @EduardoPerna1
Acompañamos con entusiasmo a las nuevas autoridades:
Presidente: Dr Walter Alarco @Walarco1
Secretario: Dr Daniel Quesada
Daniel Quesada retweeted
🌎 La Muerte Súbita Cardiaca es un desafío urgente en nuestra región.
Desde ASOCAR, con el apoyo de SIAC, presentamos la Declaración de Costa Rica: una iniciativa que promueve el abordaje multidisciplinario de la Muerte Súbita en Centroamérica y Latinoamérica.
📢 Educación, prevención, registro y acceso a terapias: ejes clave para salvar vidas.
📄 Leé y compartí la declaración completa aquí 👉 siacardio.com/academia/advoc…
🤝 Agradecemos a la Asociación Costarricense de Cardiología por liderar este esfuerzo regional.
Daniel Quesada retweeted
Felicitaciones por este gran trabajo y especialmente a mi amigo @pfelissamburu de @ICBAonline !!!!
🚨New Publication Alert: Our Landmark Study Published in the European Heart Journal!
We’re proud to share that our latest study demonstrates that EchoGo® Amyloidosis, Ultromics’ FDA-cleared AI tool, significantly improves the detection of cardiac amyloidosis using a single echocardiographic video clip.
🫀 Cardiac amyloidosis is a frequently missed, life-threatening cause of heart failure. As new disease-modifying therapies emerge, early and accurate detection is more important than ever.
💡 EchoGo® Amyloidosis is:
💙 The first FDA-cleared AI screening tool for cardiac amyloidosis
💙 Granted Breakthrough Device designation
💙 Validated in a large, multi-center, international study (n = 2,719)
💙 Highly accurate with 85% sensitivity and 93% specificity across AL, ATTRwt, and ATTRv
💙 Demonstrated superior performance vs traditional scoring systems
🌍 The study involved 18 leading global centers including Mayo Clinic, University of Chicago, Brigham and Women’s, Columbia and more.
This breakthrough shows the potential for AI to help clinicians detect cardiac amyloidosis earlier, differentiate it from similar conditions like HFpEF or hypertrophic cardiomyopathy, and expand access to life-changing therapies.
This is another important milestone for @ultromics as we continue to transform cardiovascular care with AI — not just through EchoGo® Amyloidosis, but also through our EchoGo® Heart Failure platform.
🔗 Full Publication: academic.oup.com/eurheartj/a…
With gratitude to our incredible collaborators:
@pattypellikka @JSlivnickMD Will Hawkes @sarahcud @DocStrom @AshleyAkerman
And a heartfelt tribute to the late Roberto Lang, whose leadership and vision helped make this work possible. His legacy continues through innovations like this ❤️
@ESC_Journals @escardio @ASE360 #EHJ #Echofirst #CardiacAmyloidosis #HeartFailure #AIinHealthcare #MedTech #Cardiology #DigitalHealth #EchoGo #Ultromics #Innovation #HFpEF #CardiovascularAI
Daniel Quesada retweeted
Evuzamitide....
Creo que por acá viene el futuro de la marcación de amiloidosis cardíaca.
Marcador específico con capacidad de cuantificar....
jacc.org/doi/10.1016/j.jcmg.…
Daniel Quesada retweeted
Replying to @adribaran
Amazing Congress, on the basis of academic leadership, emerging young investigators, mentoring and friendship. The result of each member effort. Congratulations SIAC for representing the Heart of the America’s
Daniel Quesada retweeted
What a privilege to have to opportunity to give this award to Professor Valentin Fuster during his visit to Colombia in SIAC2025 meeting , @upbcolombia Doctorado Honoris causa for his amazing work in cardiology.
Daniel Quesada retweeted
¡HOY! 🕑 14:00 horas.
32 Congreso Interamericano de Cardiología - SIAC 2025.
Invitados a la presentación de E-Pósters sobre insuficiencia cardíaca.
#CongresoSIAC25
@SIAC_cardio @SIAComunidad @cifacah @CongresoSIAC @EmergenciasSiac @sccccardio @FallaCardiaca
Daniel Quesada retweeted
Replying to @lucreciamburgos @adribaran @EzequielZaidel @ctinocomesquita @ManlioMarquez @drdquesada @EduardoPerna1 @SIAC_cardio @CongresoSIAC @gonzaeperez
Excelentes conferencias. Grandes oportunidades para mejora de las revistas cardiológicas latinoamericanas. @APCyCCV
Daniel Quesada retweeted
En el día 3 del #CongresoSIAC @SIAC_cardio
En la sesión de Insuficiencia aguda de @cifacah estuve hablando sobre Estrategias para optimizar la terapia depletiva
Es un honor y un gusto ser parte de este evento en Cartagena, Colombia 🇨🇴 ☺️
@RiveraToquicaMD @drjegomez @VergesAna @paomorejon @drdquesada
Daniel Quesada retweeted
Mesa @cifacah #CongresoSIAC
“Empeoramiento (Worsening) de la insuficiencia cardíaca”
¿Es de utilidad el cateterismo cardíaco en el paciente en etapa de empeoramiento?
Dra Luisa Aguilera Mora
@drdquesada @RiveraToquicaMD @rossel_victor @paomorejon @SIAC_cardio @cifacah @adribaran
Daniel Quesada retweeted
Be counted! @ICCPR_GlobalCR is updating their #GlobalCardiacRehabAudit. Help us enumerate #cardiacrehab need in your country. Click here for informed consent and survey (use Google Translate if needed): redcap.apps01.yorku.ca/surve…. Participate today and earn free access to become #ICCPRcertified!
Daniel Quesada retweeted
Colombia te espera!
Faltan 6 días para el #CONGRESOSIAC 2025 en la Ciudad de Cartagena 🇨🇴
@cifacah @rossel_victor @RiveraToquicaMD @Walarco1 @jorge_thierer @clara_clarais @SAC@SAC_54 54 @ComunidadFAC
Daniel Quesada retweeted
Alianza Contra la Muerte Súbita, una iniciativa de la @SIACardio @SIAC_cardio





























